Rh Negative in Pregnancy: RhoGAM and Rh Incompatibility
Rh negative pregnancy explained: why blood type is checked, how Rh incompatibility affects the baby, and how a RhoGAM shot at 28 weeks and after birth prevents it.
One of the first blood draws of any pregnancy answers a simple question with a big payoff: what is your blood type, and are you Rh positive or Rh negative? For most people the answer changes nothing. But for a Rh negative woman carrying a Rh positive baby, it flags a situation worth knowing about — Rh incompatibility — and, more importantly, it triggers a preventive step that has made the once-feared complication of Rh disease rare in the United States. That step is a shot of Rh immune globulin, best known by the brand name RhoGAM. This guide explains why blood type is checked in early pregnancy, what Rh incompatibility actually is, and how RhoGAM prevents it. It is part of our blood type hub, and pairs closely with our guide to the Rh factor.
Key takeaways
- Blood type (ABO) and Rh status are checked early in every pregnancy, along with an antibody screen, so your care team knows whether prevention is needed.12
- The situation that matters is Rh incompatibility: a Rh negative mother carrying a Rh positive baby (which requires an Rh positive father).34
- Without prevention, the mother's immune system can make anti-D antibodies that attack the baby's red blood cells — hemolytic disease of the fetus and newborn (HDFN).56
- RhoGAM (Rh immune globulin) prevents this. Rh negative mothers get a dose around 28 weeks and another within 72 hours after delivery if the baby is Rh positive.17
- Extra doses are given after any event that can mix fetal and maternal blood — bleeding, amniocentesis, trauma, miscarriage, or an ectopic pregnancy.15
- ABO incompatibility (usually a type O mother with a type A or B baby) is more common but far milder — mostly newborn jaundice, and no RhoGAM.46
- Thanks to routine RhoGAM, Rh disease is now highly preventable; it is very much a manageable part of prenatal care, not a reason to panic.89
Why blood type is checked in pregnancy
At your first prenatal visit, your clinician orders a type and screen: your ABO blood group (A, B, AB, or O), your Rh factor (positive or negative), and an antibody screen that looks for red-cell antibodies already in your blood.12 This is standard for every pregnancy in the U.S.
A common worry is whether you and your partner have "compatible" blood types. Reassuringly, matching or mismatched ABO types between partners do not affect your ability to conceive or, in the vast majority of cases, the pregnancy. This is not about compatibility between two adults — for that broader topic see our guide to blood type compatibility. The one thing that genuinely calls for monitoring is the mother's Rh status.
It is also worth knowing that your blood type does not change during pregnancy. If a later test reports a different type, that reflects a lab or sampling issue, not a real change.
Rh incompatibility explained
The Rh factor is a protein — the D antigen — that sits on the surface of red blood cells. If you have it, you are Rh positive; if you do not, you are Rh negative.47 About 15% of people of European ancestry are Rh negative, with lower rates in other groups.5
Rh incompatibility happens in one specific setup: a Rh negative mother carrying a Rh positive baby. Because Rh status is inherited, this only occurs when the father is Rh positive. Here is the mechanism:35
- During pregnancy — and especially at delivery — a small amount of the baby's Rh positive blood can cross into the mother's circulation.
- The mother's immune system, which has no D antigen of its own, sees these cells as foreign and makes anti-D antibodies. This is called sensitization (alloimmunization).
- Anti-D antibodies are small enough to cross the placenta. In a later pregnancy with another Rh positive baby, they can attack the baby's red blood cells.
A key point: the first Rh positive pregnancy is usually unaffected, because sensitization mostly happens at delivery, after the baby is safely born. It is subsequent pregnancies that carry the risk — which is exactly why prevention is timed to stop sensitization from ever starting.65
Hemolytic disease of the newborn (HDFN)
When maternal anti-D antibodies cross the placenta and destroy the baby's red blood cells, the result is hemolytic disease of the fetus and newborn (HDFN), historically called Rh disease or erythroblastosis fetalis.5 Breaking down red cells faster than the baby can replace them causes fetal anemia, which in severe cases leads to heart failure and dangerous fluid buildup (hydrops fetalis). After birth, the breakdown of red cells releases bilirubin, causing jaundice that, if extreme and untreated, can harm the newborn's brain.6
This is the outcome RhoGAM is designed to prevent. When HDFN does occur — usually in mothers who were sensitized before prevention was available or accessible — it is managed by specialists with tools such as Doppler ultrasound to detect fetal anemia and, when needed, intrauterine blood transfusion, followed after birth by phototherapy or exchange transfusion for jaundice.65 Modern monitoring and treatment have made even severe cases far more survivable than in the past.
RhoGAM (Rh immune globulin): the prevention
The reason Rh disease is now uncommon in the U.S. is a preventive medication: Rh immune globulin, sold under brand names such as RhoGAM.17 It is an injection of anti-D antibodies that mops up any Rh positive fetal cells in the mother's blood before her immune system reacts to them — stopping sensitization before it can begin. Because it prevents the mother from ever making her own lasting anti-D, it protects future pregnancies too.
For a Rh negative mother who is not already sensitized, the standard U.S. schedule is:17
- Around 28 weeks of pregnancy — a routine dose, because that is when the chance of small fetal–maternal bleeds starts to rise.
- Within 72 hours after delivery — a second dose, but only if the baby is confirmed Rh positive (the newborn's cord blood is typed at birth). If the baby is Rh negative, no postpartum dose is needed.
Additional doses are recommended any time fetal and maternal blood might mix, including:15
- Vaginal bleeding during pregnancy;
- Amniocentesis, chorionic villus sampling (CVS), or external cephalic version;
- Abdominal trauma (for example, a fall or car accident);
- Miscarriage, ectopic pregnancy, or an abortion.
RhoGAM works only as prevention — it does nothing once a mother is already sensitized, which is why the timing matters and why it is given routinely rather than waiting for a problem.5 Every dose is prescribed and given by your care team; this is never something to manage on your own.
ABO incompatibility
There is a second, much milder kind of blood-group mismatch: ABO incompatibility. It usually involves a type O mother carrying a baby who is type A or type B, because type O individuals naturally carry anti-A and anti-B antibodies.46 Unlike Rh disease, it can affect a first pregnancy, but it is typically mild — most often showing up as newborn jaundice that is easily treated with phototherapy. It rarely causes serious anemia.
Crucially, ABO incompatibility is not prevented with RhoGAM and does not require any injection. It is simply watched for after birth, with the newborn's bilirubin monitored and treated if needed.6
What the tests are (type & screen, antibody screen)
Two blood tests do most of the work in early pregnancy:
- Blood typing (ABO and Rh). A sample is tested to determine your ABO group and whether you are Rh positive or negative. This is the same type and screen used before any transfusion.24
- Antibody screen (indirect Coombs test). This checks whether your blood already contains anti-D or other red-cell antibodies — meaning you may have been sensitized in a past pregnancy or transfusion. A negative screen in an Rh negative mother is what allows the standard RhoGAM schedule to proceed.15
A newer refinement is cell-free fetal DNA testing: in some settings the baby's Rh type can be determined from a maternal blood sample by analyzing fetal DNA circulating in the mother's plasma. Where available, this lets clinicians skip RhoGAM when the baby is Rh negative and target it when the baby is Rh positive — avoiding unnecessary injections. European antenatal programs report sensitivity above 99.9% for this approach, and it is expanding elsewhere.910
When to talk to your doctor
Blood type and Rh testing are part of routine prenatal care, so most of this is handled for you. Still, reach out promptly if you are Rh negative and experience:
- Vaginal bleeding at any point in pregnancy;
- Abdominal trauma, such as a fall or car accident;
- A miscarriage or symptoms of ectopic pregnancy (one-sided pain, bleeding);
- An upcoming procedure such as amniocentesis or CVS.
Each of these may call for an extra dose of RhoGAM, and timing matters — ideally within 72 hours.15 If you do not know your blood type, ask; it should be on file from your first prenatal labs.
Get your prenatal labs interpreted by AI DiagMe
In pregnancy, your blood type, Rh status, and antibody screen are read together, as part of your prenatal care. Understanding these results helps you have a clearer conversation with your care team — it never replaces their guidance.
👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.
Frequently asked questions
Is it a problem if my partner and I have the same blood type?
What is Rh incompatibility?
What does RhoGAM do?
When do I get the RhoGAM shot?
Does my blood type change during pregnancy?
What if I am Rh positive?
Bottom line
In pregnancy, having the same blood type as your partner is not a risk, and ABO differences between partners almost never matter. What matters is Rh incompatibility: a Rh negative mother carrying a Rh positive baby, which can lead to hemolytic disease of the newborn. The good news is that this is highly preventable with RhoGAM (Rh immune globulin) — a dose around 28 weeks, another after delivery if the baby is Rh positive, and extra doses after any bleeding, trauma, or procedure. ABO incompatibility, though more common, is usually mild. All of it is managed with your care team. For more, see our blood type hub and our guide to the Rh factor.
Sources
Official sources and peer-reviewed publications (PubMed) used for this guide:
Footnotes
-
American College of Obstetricians and Gynecologists (ACOG) — The Rh Factor: How It Can Affect Your Pregnancy. acog.org ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Blood typing. medlineplus.gov ↩ ↩2 ↩3
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Rh incompatibility. medlineplus.gov ↩ ↩2
-
Cleveland Clinic — Rh Factor. my.clevelandclinic.org ↩ ↩2 ↩3 ↩4 ↩5
-
Hall V, Vadakekut ES, Avulakunta ID. Hemolytic Disease of the Fetus and Newborn. In: StatPearls. StatPearls Publishing, 2023. NCBI Bookshelf NBK557423 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11
-
de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth, 2023. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
Mayo Clinic — Rh factor blood test. mayoclinic.org ↩ ↩2 ↩3 ↩4
-
Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality. PLoS One, 2020. PubMed · DOI ↩
-
Clausen FB. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D− pregnant women. Immunohematology, 2024. PubMed · DOI ↩ ↩2
-
Ramsey G. The Rh blood group system: RHD update. Immunohematology, 2025. PubMed · DOI ↩